Arbutus Biopharma Corp
Biotechnology
Healthcare
ABUS
189 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
2.85
52 week high
4.56
high
3.23
52 week low
2.88
low
2.71
growth
-5.65 %
previous Close
2.88
P/E ratio
market cap
608 M
div yield
0
usd
Sep 2024
qoq
revenue
1.34 M
-22.42 %
net incoming
-19.72 M
0.40 %
eps
0.00 %
18.18 %
eps surprise
0.00 %
net profit margin
-1472.52 %
-325.00 %
operating incoming
-21.44 M
-0.32 %
net change in cash
-30.94 M
-257.17 %
cash on hand
31.85 M
-49.28 %
cost of revenue
0.00 %
top top